IMMUCELL CORP /DE/ Quarterly Liabilities and Equity in USD from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
Immucell Corp /De/ quarterly Liabilities and Equity history and growth rate from Q4 2010 to Q2 2024.
  • Immucell Corp /De/ Liabilities and Equity for the quarter ending June 30, 2024 was $41.9M, a 4.89% decline year-over-year.
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $41.9M -$2.15M -4.89% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $43.1M -$72.1K -0.17% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $43.8M -$1.05M -2.35% Dec 31, 2023 10-Q 2024-08-13
Q3 2023 $44.5M -$1.86M -4% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $44M -$1.98M -4.3% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $43.1M -$3.58M -7.66% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $44.9M +$395K +0.89% Dec 31, 2022 10-K 2024-04-01
Q3 2022 $46.4M +$2.17M +4.91% Sep 30, 2022 10-Q 2022-11-21
Q2 2022 $46M +$2.25M +5.16% Jun 30, 2022 10-Q/A 2022-11-21
Q1 2022 $46.7M +$7.08M +17.9% Mar 31, 2022 10-Q/A 2022-11-21
Q4 2021 $44.5M +$4.12M +10.2% Dec 31, 2021 10-K 2023-03-29
Q3 2021 $44.2M +$4.24M +10.6% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $43.7M +$3.07M +7.55% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $39.6M -$433K -1.08% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $40.3M +$1.66M +4.29% Dec 31, 2020 10-K 2022-03-30
Q3 2020 $40M +$1.14M +2.93% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 $40.7M +$1.25M +3.18% Jun 30, 2020 10-Q 2020-08-12
Q1 2020 $40.1M -$422K -1.04% Mar 31, 2020 10-Q 2020-05-13
Q4 2019 $38.7M +$5.96M +18.2% Dec 31, 2019 10-K 2021-03-30
Q3 2019 $38.8M +$5.61M +16.9% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $39.4M +$6.67M +20.4% Jun 30, 2019 10-Q 2019-08-12
Q1 2019 $40.5M +$6.84M +20.4% Mar 31, 2019 10-Q 2019-05-13
Q4 2018 $32.7M -$1.57M -4.57% Dec 31, 2018 10-K 2020-03-27
Q3 2018 $33.2M +$2.95M +9.73% Sep 30, 2018 10-Q 2018-11-13
Q2 2018 $32.7M +$4.68M +16.7% Jun 30, 2018 10-Q 2018-08-13
Q1 2018 $33.6M +$8.3M +32.8% Mar 31, 2018 10-Q 2018-05-14
Q4 2017 $34.3M +$9.6M +38.9% Dec 31, 2017 10-K 2019-03-22
Q3 2017 $30.3M +$9.71M +47.2% Sep 30, 2017 10-Q 2017-11-13
Q2 2017 $28.1M +$7.49M +36.4% Jun 30, 2017 10-Q 2017-08-14
Q1 2017 $25.3M +$4.95M +24.3% Mar 31, 2017 10-Q 2017-05-11
Q4 2016 $24.7M +$10.2M +69.9% Dec 31, 2016 10-K 2018-03-29
Q3 2016 $20.6M +$6.36M +44.7% Sep 30, 2016 10-Q 2016-11-10
Q2 2016 $20.6M +$9.33M +83% Jun 30, 2016 10-Q 2016-08-11
Q1 2016 $20.4M +$9.15M +81.5% Mar 31, 2016 10-Q 2016-05-11
Q4 2015 $14.5M +$3.49M +31.6% Dec 31, 2015 10-K 2017-03-30
Q3 2015 $14.2M +$3.48M +32.4% Sep 30, 2015 10-Q 2015-11-12
Q2 2015 $11.2M +$475K +4.41% Jun 30, 2015 10-Q 2015-08-13
Q1 2015 $11.2M +$114K +1.03% Mar 31, 2015 10-Q 2015-05-12
Q4 2014 $11.1M +$91.1K +0.83% Dec 31, 2014 10-K 2016-03-25
Q3 2014 $10.7M -$325K -2.93% Sep 30, 2014 10-Q 2014-11-12
Q2 2014 $10.8M -$607K -5.34% Jun 30, 2014 10-Q 2014-08-13
Q1 2014 $11.1M +$4.31K +0.04% Mar 31, 2014 10-Q 2014-05-14
Q4 2013 $11M -$69.7K -0.63% Dec 31, 2013 10-K 2015-03-26
Q3 2013 $11.1M +$94.7K +0.86% Sep 30, 2013 10-Q 2013-11-13
Q2 2013 $11.4M +$338K +3.06% Jun 30, 2013 10-Q 2013-08-13
Q1 2013 $11.1M -$59.5K -0.53% Mar 31, 2013 10-Q 2013-05-14
Q4 2012 $11M +$39.1K +0.36% Dec 31, 2012 10-K 2014-03-26
Q3 2012 $11M -$7.7K -0.07% Sep 30, 2012 10-Q 2012-11-13
Q2 2012 $11M -$252K -2.23% Jun 30, 2012 10-Q/A 2012-09-07
Q1 2012 $11.2M Mar 31, 2012 10-Q 2012-05-14
Q4 2011 $11M +$240K +2.23% Dec 31, 2011 10-K 2013-03-28
Q3 2011 $11M Sep 30, 2011 10-Q 2011-11-14
Q2 2011 $11.3M Jun 30, 2011 10-Q 2011-08-15
Q4 2010 $10.8M Dec 31, 2010 10-K 2012-03-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.